Literature DB >> 20168320

Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

Robert R Jenq1, Marcel R M van den Brink.   

Abstract

The year 2009 marked the fiftieth anniversary of the first successful allogeneic haematopoietic stem cell transplant (HSCT). The field of HSCT has pioneered some of the most exciting areas of research today. HSCT was the original stem cell therapy, the first cancer immune therapy and the earliest example of individualized cancer therapy. In this Timeline article we review the history of the development of HSCT and major advances made in the past 50 years. We highlight accomplishments made by researchers who continue to strive to improve outcomes for patients and increase the availability of this potentially life-saving therapy for patients with otherwise incurable malignancies.

Entities:  

Mesh:

Year:  2010        PMID: 20168320     DOI: 10.1038/nrc2804

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  150 in total

1.  Hematopoietic-cell transplantation at 50.

Authors:  Frederick R Appelbaum
Journal:  N Engl J Med       Date:  2007-10-11       Impact factor: 91.245

Review 2.  Shared biology of GVHD and GVT effects: potential methods of separation.

Authors:  Daniel H Fowler
Journal:  Crit Rev Oncol Hematol       Date:  2005-10-03       Impact factor: 6.312

Review 3.  Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation.

Authors:  L Ruggeri; A Mancusi; E Burchielli; F Aversa; M F Martelli; A Velardi
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 4.  Aplastic anaemia.

Authors:  Robert A Brodsky; Richard J Jones
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

5.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Authors:  P L Weiden; N Flournoy; E D Thomas; R Prentice; A Fefer; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

Review 6.  Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

Authors:  Pawel Muranski; Andrea Boni; Claudia Wrzesinski; Deborah E Citrin; Steven A Rosenberg; Richard Childs; Nicholas P Restifo
Journal:  Nat Clin Pract Oncol       Date:  2006-12

7.  Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.

Authors:  Jon J van Rood; Cladd E Stevens; Jacqueline Smits; Carmelita Carrier; Carol Carpenter; Andromachi Scaradavou
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-09       Impact factor: 11.205

8.  Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

Authors:  Neal Flomenberg; Lee Ann Baxter-Lowe; Dennis Confer; Marcelo Fernandez-Vina; Alexandra Filipovich; Mary Horowitz; Carolyn Hurley; Craig Kollman; Claudio Anasetti; Harriet Noreen; Ann Begovich; William Hildebrand; Effie Petersdorf; Barbara Schmeckpeper; Michelle Setterholm; Elizabeth Trachtenberg; Thomas Williams; Edmond Yunis; Daniel Weisdorf
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

Review 9.  Hematopoietic stem cell transplantation for primary immunodeficiency disease.

Authors:  C C Dvorak; M J Cowan
Journal:  Bone Marrow Transplant       Date:  2007-10-29       Impact factor: 5.483

10.  Purification and characterization of mouse hematopoietic stem cells.

Authors:  G J Spangrude; S Heimfeld; I L Weissman
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

View more
  101 in total

1.  Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.

Authors:  Robert G Newman; Michael J Dee; Thomas R Malek; Eckhard R Podack; Robert B Levy
Journal:  Blood       Date:  2014-03-31       Impact factor: 22.113

Review 2.  Immunopathology and biology-based treatment of steroid-refractory graft-versus-host disease.

Authors:  Tomomi Toubai; John Magenau
Journal:  Blood       Date:  2020-07-23       Impact factor: 22.113

Review 3.  Leukaemia 'firsts' in cancer research and treatment.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

Review 4.  Personal tumor antigens in blood malignancies: genomics-directed identification and targeting.

Authors:  Livius Penter; Catherine J Wu
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

5.  Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.

Authors:  Yongxia Wu; David Bastian; Steven Schutt; Hung Nguyen; Jianing Fu; Jessica Heinrichs; Changqing Xia; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-04       Impact factor: 5.742

Review 6.  Engineering Stem Cells for Biomedical Applications.

Authors:  Perry T Yin; Edward Han; Ki-Bum Lee
Journal:  Adv Healthc Mater       Date:  2015-03-13       Impact factor: 9.933

Review 7.  Adult haematopoietic stem cell niches.

Authors:  Genevieve M Crane; Elise Jeffery; Sean J Morrison
Journal:  Nat Rev Immunol       Date:  2017-06-12       Impact factor: 53.106

8.  Human peripheral blood CD4 T cell-engrafted non-obese diabetic-scid IL2rγ(null) H2-Ab1 (tm1Gru) Tg (human leucocyte antigen D-related 4) mice: a mouse model of human allogeneic graft-versus-host disease.

Authors:  L Covassin; J Laning; R Abdi; D L Langevin; N E Phillips; L D Shultz; M A Brehm
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

9.  A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activity.

Authors:  Yusuke Shono; Andrea Z Tuckett; Samedy Ouk; Hsiou-Chi Liou; Grégoire Altan-Bonnet; Jennifer J Tsai; Jennifer E Oyler; Odette M Smith; Mallory L West; Natalie V Singer; Ekaterina Doubrovina; Dmitry Pankov; Chandresh V Undhad; George F Murphy; Cecilia Lezcano; Chen Liu; Richard J O'Reilly; Marcel R M van den Brink; Johannes L Zakrzewski
Journal:  Cancer Discov       Date:  2014-02-18       Impact factor: 39.397

10.  Acoustophoretic sorting of viable mammalian cells in a microfluidic device.

Authors:  Allen H J Yang; H Tom Soh
Journal:  Anal Chem       Date:  2012-12-06       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.